High-dose sequential (HDS) chemotherapy as salvage treatment in 33 patients with refractory or relapsed non-Hodgkin's lymphoma.

被引：0
|
作者：
Tarella, C
Caracciolo, D
Gavarotti, P
Corradini, P
Zallio, F
Castellino, C
Pileri, A
机构：
[1] AZ OSP S GIOVANNI BATTISTA,DIPARTIMENTO MED & ONCOL SPERIMENTALE,TURIN,ITALY
[2] UNIV TURIN,AZ OSP S GIOVANNI BATTISTA,DIV EMATOL,TURIN,ITALY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3881 / 3881
页数：1
相关论文
共 50 条
  • [1] High-dose sequential chemotherapy in refractory Hodgkin's and non-Hodgkin's lymphoma.
    Oyan, B
    Koc, Y
    Kansu, E
    BLOOD, 2002, 100 (11) : 471B - 471B
  • [2] Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Ghielmin, M
    Benedetti, F
    Tarella, C
    Zaglio, F
    Vitolo, U
    Di Nicola, M
    Pogliani, E
    Cavalli, F
    Gianni, AM
    Barbui, T
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) : 333 - 341
  • [3] High-dose sequential chemotherapy: an effective salvage treatment for relapsed and refractory Hodgkin lymphoma
    Nassi, L
    Rigacci, L
    Guidi, S
    Alterini, R
    Carrai, V
    Lombardini, L
    Nozzoli, C
    Saccardi, R
    Vannucchi, AM
    Bosi, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S244 - S244
  • [4] Intensification of salvage treatment with dice dose sequential chemotherapy (HDS) improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin lymphoma (NHL).
    Cortelazzo, S
    Rambaldi, A
    Rossi, A
    Oldani, E
    Lussana, F
    Ghielmini, M
    Benedetti, F
    Cantini, M
    Tarella, C
    Zallio, F
    Vitolo, U
    Di Nicola, M
    Pogliani, E
    Cavalli, F
    Barbui, T
    BLOOD, 2000, 96 (11) : 794A - 794A
  • [5] High-dose sequential chemotherapy: an effective treatment for relapsed and refractory Hodgkin's lymphoma
    Nassi, L.
    Rigacci, L.
    Guidi, S.
    Alterini, R.
    Mappa, S.
    Carrai, V.
    Lombardini, L.
    Nozzoli, C.
    Puccini, B.
    Saccardi, R.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S320 - S321
  • [6] The high-dose sequential (HDS) chemotherapy regimen as salvage treatment in 110 refractory/relapsed Hodgkin's Lymphoma patients: A multicentre, retrospective evaluation of the Italian Lymphoma Intergroup.
    Tarella, C
    Cuttica, A
    Vitolo, U
    Liberati, M
    Di Nicola, M
    Cortelazzo, S
    Coser, P
    Di Renzo, N
    Musso, M
    Pavone, E
    Santini, G
    Pescarolo, A
    De Crescenzo, A
    Federico, M
    Gallamini, A
    Boccomini, C
    Romano, R
    Rosanelli, C
    Gallo, E
    Barbui, T
    Gianni, AM
    Pileri, A
    Levis, A
    BLOOD, 2001, 98 (11) : 862A - 862A
  • [7] Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma
    Machover, D
    Delmas-Marsalet, B
    Misra, SC
    Gumus, Y
    Goldschmidt, E
    Schilf, A
    Frénoy, N
    Emile, JF
    Debuire, B
    Guettier, C
    Farrokhi, P
    Boulefdaoui, B
    Norol, F
    Parquet, N
    Ulusakarya, A
    Jasmin, C
    ANNALS OF ONCOLOGY, 2001, 12 (10) : 1439 - 1443
  • [8] Favorable influence of rituximab with high dose sequential chemotherapy (R-HDS) programs and autologous stem cell transplantation (ASCT) in salvage treatment for patients with refractory or relapsed B-cell non-Hodgkin's lymphoma.
    Pintimalli, Milena
    Mian, Michael
    Rossi, Andrea
    Sorio, Marco
    Benedetti, Fabio
    Pizzolo, Giovanni
    Billio, Atto
    Barbui, Tiziano
    Rambaldi, Alessandro
    Cortelazzo, Sergio
    BLOOD, 2006, 108 (11) : 776A - 776A
  • [9] Comparison of the sequential high-dose chemotherapy followed by autologous stem cell support with and without rituximab in relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Sieniawski, M
    Staak, JO
    Scheuss, H
    Glossmann, JP
    Diehl, V
    Engert, A
    Josting, A
    BLOOD, 2004, 104 (11) : 263A - 263A
  • [10] Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
    Mey, Ulrich J. M.
    Orlopp, Katjana S.
    Flieger, Dimitri
    Strehl, John W.
    Ho, Anthony D.
    Hensel, Manfred
    Bopp, Cordula
    Gorschlueter, Marcus
    Wilhelm, Martin
    Birkmann, Josef
    Kaiser, Ulrich
    Neubauer, Andreas
    Florschuetz, Axel
    Rabe, Christian
    Hahn, Corinna
    Glasmacher, Axel G.
    Schmidt-Wolf, Ingo G. H.
    CANCER INVESTIGATION, 2006, 24 (06) : 593 - 600
12345